<DOC>
	<DOCNO>NCT00584155</DOCNO>
	<brief_summary>The purpose study determine Lactated Ringer 's solution effective patient undergo chemotherapy cisplatin head neck cancer regard cisplatin-induced hearing loss .</brief_summary>
	<brief_title>Protection From Cisplatin Ototoxicity Lactated Ringers</brief_title>
	<detailed_description>About one-third people give Cisplatin , part chemotherapy treatment , develop hearing loss . The purpose study determine degree hearing loss prevent use Lactated Ringer 's solution middle ear . To study , patient use drops ear ; Lactated Ringer 's place one ear inactive saline solution place . Ofloxacin , eardrop antibiotic place ear time . Each participant receive hearing evaluation dose Cisplatin another evaluation 2 4 week final treatment .</detailed_description>
	<mesh_term>Hearing Loss</mesh_term>
	<mesh_term>Deafness</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<criteria>Patients cancer treat cisplatin . Patients expect receive minimum 3 round chemotherapy . Patients receive minimum dose cisplatin 70 mg/m2 Patients middle ear surgery . Patients active external middle ear disease Patients precede pure tone average &gt; 40 dB HL</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Cisplatin Ototoxicity</keyword>
	<keyword>Lactated Ringer 's</keyword>
	<keyword>Ear Cancer</keyword>
	<keyword>Hearing loss</keyword>
	<keyword>Hearing loss due Cisplatin Ototoxicity</keyword>
</DOC>